يعرض 1 - 10 نتائج من 59 نتيجة بحث عن '"Bajars M"', وقت الاستعلام: 1.28s تنقيح النتائج
  1. 1
    مؤتمر
    Safety of avelumab (MSB0010718C), an anti-PD-L1 antibody : updated analysis from the phase Ib JAVELIN solid tumor trial

    المؤلفون: Kelly, K., Patel, M., Infante, J.R., Iannotti, N., Nikolinakos, P., Leach, J., Wang, D., Chandler, J., JERUSALEM, Guy, Gurtler, J., Arkenau, H-T., Bajars, M., von Heydebreck, A., Speit, I., Heery, Ch., Gulley, J.L.

    مصطلحات موضوعية: oncology, Human health sciences :: Oncology, Sciences de la santé humaine :: Oncologie

    جغرافية الموضوع: international

    Relation: CT132; American Association for Cancer Research Annual Meeting, New Orleans, United States (April 16-20, 2016)

    URL الوصول: https://orbi.uliege.be/handle/2268/199890

    أضف إلى المفضلة
  2. 2
    مؤتمر
    Avelumab (MSB0010718C ; anti-PD-L1) as a first-line treatment for patients with advanced NSCLC from the JAVELIN Solid Tumor phase 1b trial : safety, clinical activity, and PD-L1 expression

    المؤلفون: Verschraegen, C., Chen, F.L., Spigel, D.R., Iannotti, N., McClay, E., Redfern, C.H., Bennouna, J., Taylor, M., Kaufman, H., Kelly, K., Bajars, M., von Heydebreck, A., Cuillerot, J-M., JERUSALEM, Guy

    المصدر: Avelumab (MSB0010718C ; anti-PD-L1) as a first-line treatment for patients with advanced NSCLC from the JAVELIN Solid Tumor phase 1b trial : safety, clinical activity, and PD-L1 expression. Journal of Clinical Oncology, 34, 9036.Alexandria, VAAmerican Society of Clinical Oncology. (2016).

    مصطلحات موضوعية: oncology, Human health sciences :: Oncology, Sciences de la santé humaine :: Oncologie

    Relation: 2016 ASCO Annual Meeting, Chicago, United States (June 3-7, 2016)

    URL الوصول: https://orbi.uliege.be/handle/2268/199550

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    XRay Vision: A Phase 3 Study of Xevinapant Plus Radiotherapy (RT) for High-risk, Cisplatin-ineligible Patients with Resected, Locally Advanced Squamous Cell Carcinoma of the Head and Neck (LA SCCHN)

    المؤلفون: Ferris, R.L., Mehanna, H., Schoenfeld, J.D., Tahara, M., Yom, S.S., Haddad, R.I., König, A., Salmio, S., Bajars, M., Tourneau, C. Le

    المصدر: In International Journal of Radiation Oncology, Biology, Physics 1 April 2024 118(5):e17-e18

    View record from ScienceDirect Full Text via ClinicalKey Full Text Finder
    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Adjusted RECIST Criteria for Assessing Time to Recurrence in Patients with Fully Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN)

    المؤلفون: Eggleton, S.P., O'Neal, M., Ford, R., Schroeder, A., Bajars, M., Tourneau, C. Le, Ferris, R.L.

    المصدر: In International Journal of Radiation Oncology, Biology, Physics 1 April 2024 118(5):e16-e16

    View record from ScienceDirect Full Text via ClinicalKey Full Text Finder
    أضف إلى المفضلة
  5. 5
    دورية أكاديمية

    لا يتم عرض هذه النتيجة على الضيوف.

    View record in Scopus
    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    RWD42 Patient Characteristics and Treatment Patterns in Patients With Persistent, Recurrent, or Metastatic (P/R/M) Cervical Cancer: A Real-World Data Analysis in the US

    المؤلفون: Mahmoudpour, SH, Ting, S, Schoenherr, N, Bajars, M, Verpillat, P, Randall, L

    المصدر: In Value in Health December 2022 25(12) Supplement:S456-S456

    View record from ScienceDirect Full Text via ClinicalKey Full Text Finder
    أضف إلى المفضلة
  7. 7
    دورية أكاديمية
    1689P Adverse event management during treatment with bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1: Treatment guidelines based on experience in clinical trials

    المؤلفون: Gulley, J., Lacouture, M.E., Spira, A., Mata, H. Verdaguer, Yoo, C., Cho, B.C., Helwig, C., Halady, T., Valencia, C., Bajars, M., Strauss, J., Brownell, I.

    المصدر: In Annals of Oncology September 2021 32 Supplement 5:S1181-S1182

    أضف إلى المفضلة
  8. 8
    دورية أكاديمية
    1092P Non-progression with avelumab treatment in patients with metastatic Merkel cell carcinoma (mMCC) is associated with a clinically meaningful better health-related quality of life compared with progressive disease

    المؤلفون: Bharmal, M., Nolte, S., Lebbé, C., Mortier, L., Brohl, A.S., Fazio, N., Grob, J-J., Prinzi, N., Hanna, G.J., Hassel, J., Kiecker, F., Ellers-Lenz, B., Bajars, M., Guezel, G., Nghiem, P., Hunger, M., Schlichting, M., Henry-Szatkowski, M., D'Angelo, S.

    المصدر: In Annals of Oncology September 2020 31 Supplement 4:S740-S741

    أضف إلى المفضلة
  9. 9
    دورية أكاديمية
    920P Avelumab (anti-PD-L1) in patients with platinum-refractory/ineligible recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): Results from a phase Ib cohort

    المؤلفون: Guigay, J., Lee, K-W., Patel, M.R., Daste, A., Wong, D.J., Goel, S., Gordon, M., Gutierrez, M., Balmanoukian, A., Le Tourneau, C., Mita, A., Vansteene, D., Keilholz, U., Schöffski, P., Grote, H.J., Zhou, D., Bajars, M., Penel, N.

    المصدر: In Annals of Oncology September 2020 31 Supplement 4:S664-S664

    أضف إلى المفضلة
  10. 10
    دورية أكاديمية
    PCN8 COMPARING PATIENT-RELEVANT ENDPOINT WITH CLINICAL ENDPOINT IN A RARE DISEASE: THE CASE OF METASTATIC MERKEL CELL CARCINOMA TREATED WITH AVELUMAB

    المؤلفون: Bharmal, M., Nolte, S., Lebbe, C., Mortier, L., Brohl, A.S., Fazio, N., Grob, J.J., Pusceddu, S., Hanna, G.J., Hassel, J.C., Kiecker, F., Ellers-Lenz, B., Bajars, M., Güzel, G., Nghiem, P., Hunger, M., Schlichting, M., Henry-Szatkowski, M., D'Angelo, S.P.

    المصدر: In Value in Health May 2020 23 Supplement 1:S23-S23

    View record from ScienceDirect Full Text via ClinicalKey Full Text Finder
    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء